Noticias de Eulerpool SpringWorks Therapeutics

SpringWorks Therapeutics Noticias de Acciones

SpringWorks Therapeutics es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de SpringWorks Therapeutics.

• 18 de julio ·

  Yahoo
  European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
• 2 de julio ·

  Yahoo
  Merck concludes SpringWorks acquisition for $3.4bn
• 1 de julio ·

  Yahoo
  Merck KGaA, Darmstadt, Germany Completes Acquisition of SpringWorks Therapeutics to Accelerate Sustainable Growth of its Healthcare Business
• 20 de junio ·

  Yahoo
  SpringWorks Therapeutics Receives Positive CHMP Opinion for Nirogacestat for the Treatment of Adults with Desmoid Tumors
• 28 de mayo ·

  SeekingAlpha
  Carillon Eagle Small Cap Growth Fund Q1 2025 Commentary
• 27 de mayo ·

  Yahoo
  High Growth Tech Stocks in the US to Watch This May 2025
• 23 de mayo ·

  Yahoo
  SpringWorks Therapeutics Receives Positive CHMP Opinion for Mirdametinib for the Treatment of Adult and Pediatric Patients with NF1-PN
• 9 de mayo ·

  SeekingAlpha
  Biotech Outperformance - Can't Take What's Already Earned
• 1 de mayo ·

  Yahoo
  Biotech Alert: Searches spiking for these stocks today
• 29 de abril ·

  SeekingAlpha
  SpringWorks: Acquired By Merck KGaA Based On Rare Tumor Targeting Drugs Like OGSIVEO